Has Rustin Licht received payments from drug or device companies?

Yes. Drug and device makers reported $2,531 in general payments to Rustin Licht across 169 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rustin Licht did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rustin Licht come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rustin Licht

Psychiatry · Iowa City, IANPI 1619210549

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 25.9% of the total. Reporting peaked in 2023 at $690 and has fallen 88.3% since, to $80 in 2025.

$2,531in general payments, 2019–2025

Across 169 payments — averaging $14.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$654
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$288
Otsuka America Pharmaceutical, Inc.$238
Lundbeck LLC$133
Corium, LLC$114
Takeda Pharmaceuticals U.S.A., Inc.$104
plus $999 from 17 others

What the payments were for

Food & beverage$2,531100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	53	$654
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	23	$288
Otsuka America Pharmaceutical, Inc.	13	$238
Lundbeck LLC	8	$133
Corium, LLC	7	$114
Takeda Pharmaceuticals U.S.A., Inc.	6	$104
Jazz Pharmaceuticals Inc.	5	$100
Vanda Pharmaceuticals Inc.	4	$94
Shire North American Group Inc	6	$87
Teva Pharmaceuticals USA, Inc.	5	$87
Supernus Pharmaceuticals, Inc.	5	$81
Bausch Health US, LLC	5	$78
Ironshore Pharmaceuticals Inc.	4	$72
Neos Therapeutics, LP	4	$72
Axsome Therapeutics, Inc.	4	$68
Neurocrine Biosciences, Inc.	4	$63
Alkermes, Inc.	2	$42
Johnson & Johnson	2	$32
Sunovion Pharmaceuticals Inc.	3	$32
Adlon Therapeutics L.p.	2	$30
Idorsia Pharmaceuticals US Inc	2	$28
Itamar Medical Inc	1	$17
Merck	1	$16

How this compares

$2,531 in reported general payments places this provider in the 85th percentile of 245 psychiatry providers in Iowa.

See all psychiatry providers in Iowa →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ziprasidone Hcl	12	$2,555
Clonidine Hcl	16	$18

Paid to pharmacies, not to this prescriber.

Other psychiatry in Iowa City

Donald BlackIowa City$19K
William CoryellIowa City$18K
Peggy NopoulosIowa City$11K
Douglas LangbehnIowa City$8K
Evan OuyangIowa City$2K
Laurie McPearceIowa City$2K
Nicholas TrappIowa City$1K
Kimberly VerhoefIowa City$1K
Desire ChristensenIowa City$1K
Dana WeibelIowa City$1K

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →